Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
Antipsychotic, Apotex, Armitage, Axid, boxed, CATIE, Circuit, communicating, confidential, Dau, delivery, depreciated, earliest, Eli, ELSI, escrow, extend, extendible, faster, finance, gain, gathering, glucose, indirect, inquiry, Intervention, irrelevant, joined, label, lipid, master, mature, maturity, Mental, metabolism, monthly, National, Novopharm, omitted, Ortiz, parent, pen, pharmacy, responding, restitution, retirement, Robert, schizophrenia, showed, significantly, statistically, study, subsidiary, suicidal, superior, system, Tringali, uncommon, unconditionally, violative, working
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 the Eli Lilly and Company Bonus Plan, As Amended
- 10.2 Master Settlement Agreement
- 11 Statement Re: Computation of Earnings (Loss) Per Share
- 12 Statement Re: Computation of Ratio of Earnings
- 31.1 Rule 13A-14(A) Certification of Sidney Taurel
- 31.2 Rule 13A-14(A) Certification of Charles E. Golden
- 32 Section 1350 Certification
- 99 Cautionary Statement
Related press release
LLY similar filings
Filing view
External links
EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Unaudited)
Eli Lilly and Company and Subsidiaries
(Dollars in millions)
(Dollars in millions)
Nine Months | ||||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
September 30, | Years Ended December 31, | |||||||||||||||||||||||
2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |||||||||||||||||||
Consolidated pretax income | $ | 1,822.8 | $ | 2,941.9 | $ | 3,261.7 | $ | 3,457.7 | $ | 3,506.9 | $ | 3,858.7 | ||||||||||||
Interest | 166.0 | 162.9 | 121.9 | 140.0 | 253.3 | 225.4 | ||||||||||||||||||
Less interest capitalized during the period | (105.1 | ) | (111.3 | ) | (60.9 | ) | (60.3 | ) | (61.5 | ) | (43.1 | ) | ||||||||||||
Earnings | $ | 1,883.7 | $ | 2,993.5 | $ | 3,322.7 | $ | 3,537.4 | $ | 3,698.7 | $ | 4,041.0 | ||||||||||||
Fixed charges | $ | 166.0 | $ | 162.9 | $ | 121.9 | $ | 140.0 | $ | 253.3 | $ | 225.4 | ||||||||||||
Ratio of earnings to fixed charges | 11.3 | 18.4 | 27.3 | 25.3 | 14.6 | 17.9 | ||||||||||||||||||